細胞表面標誌物的全球市場 - 市場規模、佔有率、成長分析：按類型、按應用分類 - 產業預測（2023-2030）

Global Cell Surface Markers Market Size, Share, Growth Analysis, By Type(Flow cytometers, hematology anlayzers and reagents and kits), By Application(Disease diagnosis and identification and research/drug discovery) - Industry Forecast 2023-2030

出版日期: 2023年10月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2021年全球細胞表面標誌物市場規模為259.2億美元，2022年為279.9億美元。預計該市場在預測期（2023-2030年）將以8%的年複合成長率成長，到2030年達到518.1億美元。

全球細胞表面標誌物市場是一個快速成長且充滿活力的行業，在醫學研究、診斷和藥物開發等各個領域發揮重要作用。細胞表面標誌物，也稱為細胞表面抗原或分化簇 (CD) 標記，是位於細胞外表面的蛋白質或分子，可作為識別特定細胞類型的標籤。這些標記物廣泛用於識別、分離和表徵不同的細胞群，有助於了解細胞功能、疾病機制和治療標靶。該市場的推動因素包括慢性病的增加、個人化醫療需求的增加、流式細胞儀和其他細胞分析技術的進步以及研發活動投資的增加。此外，細胞表面標誌物在腫瘤學、免疫學、幹細胞研究、感染疾病等領域的不斷擴大應用也進一步推動了市場的成長。然而，先進細胞分析設備的高成本和細胞表面標誌物分析的複雜性等挑戰限制了市場潛力。然而，持續的技術進步，例如多重、高通量分析平台的開發，有可能克服這些障礙並推動全球細胞表面標誌物市場的未來成長。

全球細胞表面標誌物市場的關鍵促進因素之一是慢性病盛行率的上升。癌症、自體免疫疾病等慢性疾病的盛行率不斷上升，推動了對細胞表面標誌物的需求。這些標記物在疾病診斷、預後和標靶治療中發揮重要作用，有助於個人化醫療的方法。全球慢性病負擔日益加重，推動了對先進細胞分析技術的需求，推動了整體市場的成長。

全球細胞表面標誌物市場的主要抑制因素是先進細胞分析設備和技術的高成本。與先進的流式細胞儀、血液分析儀和其他細胞分析平台相關的採購和維護成本可能很高。此外，用於細胞表面標誌物分析的試劑和試劑盒的成本是巨大的。高昂的進入和營運成本限制了先進細胞分析技術的取得和採用，特別是在資源有限的環境和新興市場中。這對市場成長構成了挑戰，特別是在醫療保健系統普及對成本敏感的地區。

該報告研究了全球細胞表面標誌物市場，並提供了市場概述，包括按類型、應用、區域和參與市場的公司概況分類的趨勢。

主要企業簡介
- Thermo Fisher Scientific
- QIAGEN NV
- Bio-Rad Laboratories
- F. Hoffman-La Roche
- BD
- Grifols SA
- GenScript
- Siemens Healthcare Private Limited
- Abcam plc.
- Merck KGaA
- Beckman Coulter, Inc.
- Agilent Technologies
- Sysmex Corporation
- Lonza Group Ltd.
- BioLegend, Inc.
- Novus Biologicals
- Miltenyi Biotec
- Cell Signaling Technology
- Sino Biological Inc.
- R&D Systems

簡介目錄

Product Code: SQMIG35J2063

Global Cell Surface Markers Market size was valued at USD 25.92 billion in 2021 and is poised to grow from USD 27.99 billion in 2022 to USD 51.81 billion by 2030, at a CAGR of 8% during the forecast period (2023-2030).

The global cell surface markers market is a rapidly growing and dynamic industry that plays a crucial role in various fields, including medical research, diagnostics, and drug development. Cell surface markers, also known as cell surface antigens or cluster of differentiation (CD) markers, are proteins or molecules present on the outer surface of cells, which serve as identification tags for specific cell types. These markers are extensively utilized in the identification, isolation, and characterization of different cell populations, aiding in the understanding of cell function, disease mechanisms, and therapeutic targeting. The market is driven by factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, advancements in flow cytometry and other cell analysis techniques, and growing investments in research and development activities. Additionally, the expanding applications of cell surface markers in oncology, immunology, stem cell research, and infectious diseases further propel market growth. However, challenges such as the high cost of advanced cell analysis instruments and the complexity of cell surface marker analysis limit the market's full potential. Nevertheless, ongoing technological advancements, such as the development of multiplexed and high-throughput analysis platforms, hold promise for overcoming these barriers and driving the future growth of the global cell surface markers market.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Surface Markers Market Segmental Analysis

Global Cell Surface Markers Market is segmented on the basis of type, application, and region. Based on type, the market can be segmented into Flow cytometers, hematology anlayzers and reagents and kits. Based on application, the market is segmented into Disease diagnosis and identification and research/drug discovery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Cell Surface Markers Market Dynamics

Drivers for Global Cell Surface Markers Market

Increasing prevalence of chronic diseases

One key driver of the global cell surface markers market is the increasing prevalence of chronic diseases. The rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, drives the demand for cell surface markers. These markers play a crucial role in disease diagnosis, prognosis, and targeted therapies, aiding in personalized medicine approaches. The growing burden of chronic diseases worldwide fuels the demand for advanced cell analysis techniques and drives the overall market growth.

Restraints in the Global Cell Surface Markers Market

High cost of advanced cell analysis instruments and techniques

A key restraint of the global cell surface markers market is the high cost of advanced cell analysis instruments and techniques. The acquisition and maintenance costs associated with sophisticated flow cytometers, hematology analyzers, and other cell analysis platforms can be significant. Additionally, the cost of reagents and kits used in cell surface marker analysis can also be substantial. The high cost of entry and operation limits the accessibility and adoption of advanced cell analysis technologies, especially in resource-constrained settings and emerging markets. This poses a challenge for market growth, particularly in regions where cost-sensitive healthcare systems prevail.

Market Trends of Global Cell Surface Markers Key

Increasing focus on personalized medicine

One key market trend in the global cell surface markers market is the increasing focus on personalized medicine. Personalized medicine aims to tailor medical treatments to individual patients based on their unique characteristics, including cell surface markers. Cell surface markers play a vital role in identifying specific cell populations and determining their response to therapies. The growing understanding of the role of cell surface markers in disease progression and treatment response has led to the development of targeted therapies that can be customized based on an individual's cell surface marker profile. This trend towards personalized medicine is driving the demand for advanced cell analysis techniques and innovative cell surface marker detection methods in the market.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Cell Surface Markers Market by Type
- Market Overview
- Flow cytometers
- hematology anlayzers and reagents and kits
Global Cell Surface Markers Market by Application
- Market Overview
- Disease diagnosis and identification and research/drug discovery
Global Cell Surface Markers Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- QIAGEN N.V. (Netherlands)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad Laboratories (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- F. Hoffman-La Roche (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BD (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Grifols SA (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GenScript (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Siemens Healthcare Private Limited (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abcam plc. (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beckman Coulter, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Agilent Technologies (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sysmex Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lonza Group Ltd. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLegend, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novus Biologicals (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Miltenyi Biotec (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cell Signaling Technology (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sino Biological Inc. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- R&D Systems (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments